Willis Towers Watson Public (NASDAQ:WTW – Get Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 16.000-17.000 for the period, compared to the consensus estimate of 16.500. The company issued revenue guidance of $9.9 billion-, compared to the consensus revenue estimate of $9.9 billion. Willis Towers Watson Public also updated its FY24 guidance to $16.00-17.00 EPS.
Willis Towers Watson Public Stock Down 1.0 %
WTW traded down $2.89 during trading on Friday, hitting $299.30. The company had a trading volume of 710,112 shares, compared to its average volume of 540,174. The firm’s 50-day moving average price is $291.95 and its 200 day moving average price is $273.16. The company has a market capitalization of $30.40 billion, a PE ratio of -41.11, a PEG ratio of 1.90 and a beta of 0.73. The company has a quick ratio of 1.94, a current ratio of 1.72 and a debt-to-equity ratio of 0.70. Willis Towers Watson Public has a one year low of $232.77 and a one year high of $308.87.
Willis Towers Watson Public (NASDAQ:WTW – Get Free Report) last posted its quarterly earnings data on Thursday, October 31st. The company reported $2.93 earnings per share for the quarter, topping the consensus estimate of $2.68 by $0.25. The company had revenue of $2.29 billion during the quarter, compared to analysts’ expectations of $2.28 billion. Willis Towers Watson Public had a positive return on equity of 18.57% and a negative net margin of 7.36%. Willis Towers Watson Public’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.24 earnings per share. As a group, equities analysts expect that Willis Towers Watson Public will post 16.55 earnings per share for the current year.
Willis Towers Watson Public Announces Dividend
Analyst Ratings Changes
A number of research analysts recently weighed in on the stock. Keefe, Bruyette & Woods raised their target price on shares of Willis Towers Watson Public from $320.00 to $323.00 and gave the company an “outperform” rating in a research report on Wednesday, July 31st. UBS Group raised Willis Towers Watson Public to a “hold” rating in a research report on Wednesday, October 9th. Morgan Stanley decreased their target price on shares of Willis Towers Watson Public from $275.00 to $272.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 10th. Jefferies Financial Group upped their price target on shares of Willis Towers Watson Public from $295.00 to $314.00 and gave the stock a “hold” rating in a research report on Wednesday, October 9th. Finally, Wells Fargo & Company lifted their price objective on shares of Willis Towers Watson Public from $321.00 to $334.00 and gave the company an “overweight” rating in a research report on Thursday, October 3rd. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $309.47.
Read Our Latest Stock Report on Willis Towers Watson Public
About Willis Towers Watson Public
Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. It operates through two segments: Health, Wealth & Career and Risk & Broking. The company offers strategy and design consulting, plan management service and support, broking and administration services for health, wellbeing, and other group benefit program, including medical, dental, disability, life, voluntary benefits and other coverages; actuarial support, plan design, and administrative services for pension and retirement savings plans; retirement consulting services and solutions; and integrated solutions that consists of investment discretionary management, pension administration, core actuarial, and communication and change management assistance services.
Recommended Stories
- Five stocks we like better than Willis Towers Watson Public
- What is MarketRank™? How to Use it
- Battle of the Retailers: Who Comes Out on Top?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- 3 Healthcare Dividend Stocks to Buy
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Willis Towers Watson Public Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willis Towers Watson Public and related companies with MarketBeat.com's FREE daily email newsletter.